News

Planning Surgery Using 3D Printing in Practice –⁠ Case Study

25. 1. 2024 Source: medScope.pro

In October 2023, an article by neurosurgeons from Leipzig University was published in the journal 3D Printing in Medicine, focusing on the use of 3D printing in the treatment of complex post-traumatic elbow stiffness. According to the article, the 3D model is a suitable supplement for pre-operative planning, conducting the surgery itself, and post-operative control.

Immunomodulation and Romiplostim −⁠ What Does the Recently Published iROM Study Say?

Primary immune thrombocytopenia (ITP) is caused by an immunity disorder, involving not only the production of antibodies but also changes in cytokine levels, predominance of Th1 lymphocytes over Th2,…

24. 1. 2024 Source: Immune Thrombocytopenia

ICIS Report: Potential of TPO-RA as Early Immunomodulatory Treatment of Immune Thrombocytopenia

The report from the meeting of the Intercontinental Cooperative ITP Study Group (ICIS) in 2022 in Lenzerheide, Switzerland, published late last year in the British Journal of Haematology, discusses…

24. 1. 2024 Source: Immune Thrombocytopenia

Impact of Azacitidine Maintenance Therapy on Survival of Patients with AML in Remission Depending on Initial Chemotherapy

The QUAZAR AML-001 study showed that oral azacitidine maintenance therapy significantly prolongs relapse-free survival (RFS) and overall survival (OS) in patients with acute myeloid leukemia (AML) in…

24. 1. 2024 Source: Acute Myeloid Leukemia

Doc. Milan Sova: AAT substitution is available to all indicated patients. It is therefore crucial to now educate about the necessity of regular treatment

Alpha-1-antitrypsin deficiency (AATD) is one of the most common genetic disorders in adults. It is usually associated with the early development of chronic obstructive pulmonary disease (COPD) or…

18. 1. 2024 Source: Deficiency of Alpha-1-Antitrypsin

Anabolic Antiosteoporotic Treatment as a First Step in Patients with Very High Fracture Risk

According to the 2022 opinion of the ESCEO (European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases) working group, it is advisable to identify…

18. 1. 2024 Source: Osteoporosis – Trends in Sequential Therapy

Cardio-renal-metabolic syndrome in context

The increase in the incidence of type 2 diabetes mellitus (T2DM), cardiovascular diseases (CVD), and chronic kidney disease (CKD) ranks among the most significant health issues of our time. Based on recent...

16. 1. 2024 Source: Heart Failure

MUDr. Petra Garnolová: The combination of medical cannabis with other analgesics is the ideal way to achieve the best effect with the fewest side effects

Medical cannabis is gradually finding its way to many patients with various ailments, including those with unmanageable and hard-to-influence chronic pain. For them, this therapy can offer a new…

8. 1. 2024 Source: Medical Cannabis

Calculator Naxiva -⁠ Application for Easy Prescription of Medical Cannabis Extracts

The new Calculator Naxiva application, specifically designed for doctors prescribing medical cannabis, allows for a simple conversion of its doses to the Naxiva Panaxol extract. Quickly and easily,…

8. 1. 2024 Source: Medical Cannabis

A Decade of Therapy Targeting B Lymphocytes in MS

Ocrelizumab is not only a pioneer but also a highly effective and still promising modality for the treatment of multiple sclerosis (MS) with excellent patient adherence and persistence.

3. 1. 2024 Source: Neurology - Multiple Sclerosis

1 … 22 23 24 25 26 … 171

Back Filter by speciality

Remove filters